December 14, 2006

FOR RELEASE:  Immediately

CTS Corporation’s Scotland Facility Achieves ISO13485 Certification for Medical Manufacturing

Elkhart, IN…CTS Corporation (NYSE: CTS), a leading provider of electronics manufacturing services, announced today that the Scotland facility of its Electronics Manufacturing Solutions (EMS) strategic business unit, has successfully achieved ISO13485:2003 certification.

ISO13485:2003 is the international quality management standard for designers and manufacturers of medical devices. CTS actively pursued this certification as part of an ongoing global quality roadmap to meet the needs of customers in the high reliability, high technology medical sector. Scotland is CTS’ first European facility to achieve the accreditation. 

Don Schroeder, President of CTS EMS, commented, “The achievement of ISO13485 in the UK means that CTS has successfully obtained ISO13485 status in North America, Asia and Europe - six of our eight facilities are now accredited and we expect to accomplish a seventh in Q1 of next year as part of our strategy to serve customers with a need for higher complexity medical devices and equipment in their home region. I am proud that the team continues to delight our customers with world class excellence.”  

CTS’ range of products and services provided to the medical sector includes highly complex, high-reliability SMT assemblies and backplanes, fully integrated box build systems, global NPI to support clinical trials, equipment design, micro-electronic assembly and clean room environments.
 

About CTS EMS
CTS EMS is a provider of electronics manufacturing products and services to a range of markets, including communications, medical, defense, aerospace, and industrial equipment. With headquarters in Moorpark, California, CTS operates eight manufacturing facilities worldwide in Europe, North America and Asia.  
 

About CTS
CTS is a leading designer and manufacturer of electronic components and sensors and a provider of electronics manufacturing services (EMS) to OEMs in the automotive, computer, communications, medical and industrial markets. CTS manufactures products in North America, Europe and Asia. CTS' stock is traded on the NYSE under the ticker symbol "CTS.” 
 

Safe Harbor Statement
This press release contains statements that are, or may be deemed to be, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  These forward-looking statements include, but are not limited to, any financial or other guidance, statements that reflect our current expectations concerning future results and events, and any other statements that are not based solely on historical fact.  Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.  These forward-looking statements are made subject to certain risks, uncertainties and other factors, which could cause our actual results, performance or achievements to differ materially from those presented in the forward-looking statements.  For more detailed information on the risks and uncertainties associated with CTS’ business, see our reports filed with the SEC.  CTS undertakes no obligation to publicly update its forward-looking statements to reflect new information or events or circumstances that arise after the date hereof, including market or industry changes.